The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Atypical Antipsychotic Drugs and Alzheimer's Disease
Hussain, H. M., Hotopf, M. H., & Oyebode, F. (2007) · New England Journal of Medicine · doi:10.1056/nejmc063094 · Cited by 8
RetractedEffectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
Pinquart, M., & Sörensen, S. (2003) · Psychology and Aging · doi:10.1037/0882-7974.18.2.250 · Cited by 2,857 · cited 1×
“The myriad of adverse psychological and physical consequences of caregiver stress has been reviewed (Pinquart and Sorensen, 2003).”
BackgroundThe Neuropsychiatric Inventory: Assessing psychopathology in dementia patients
Cummings, J. L. (1997) · Neurology · doi:10.1212/wnl.48.5_suppl_6.10s · Cited by 2,017
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671 · cited 2×
“…a meta-analysis noted that, in two RCTs including haloperidol, the increased risk of death in dementia patients treated with haloperidol relative to placebo (OR 1.7, 95% CI 0.7–3.9) was similar to the average increase in risk reported with atypical drugs relative to placebo (Schneider et al, 2005).”
BackgroundResultInfluentialSelf-citationEvans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,626
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.1989.03430180093036 · Cited by 1,226 · cited 1×
“Among US adults over age 65, prevalence estimates of dementia range from 5 to 15%, with Alzheimer’s Disease (AD) being the most common type of dementia (Kaplan and Sadock, 1998; Evans et al, 1989; Losonczy et al, 1998).”
BackgroundEffectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
Schneider, L. S., Tariot, P. N., Dagerman, K. S., Davis, S. M., Hsiao, J. K., Ismail, M. S., Lebowitz, B. D., Lyketsos, C. G., Ryan, J. M., Stroup, T. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061240 · Cited by 1,206
Self-citationMcKeith, I., Del Ser, T., Spano, P., Emre, M., Wesnes, K., Anand, R., Cicin-Sain, A., Ferrara, R., & Spiegel, R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03399-7 · Cited by 1,182
Lyketsos, C. G., Steinberg, M., Tschanz, J. T., Norton, M. C., Steffens, D. C., & Breitner, J. C. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.708 · Cited by 1,144
Jones, P. B., Barnes, T. R. E., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K. P., Murray, R. M., Markwick, A., & Lewis, S. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1079 · Cited by 1,105
Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications
Wang, P. S., Schneeweiss, S., Avorn, J., Fischer, M. A., Mogun, H., Solomon, D. H., & Brookhart, M. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052827 · Cited by 959
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence
Sink, K. M., Holden, K. F., & Yaffe, K. (2005) · JAMA · doi:10.1001/jama.293.5.596 · Cited by 910
Self-citationPatient and Caregiver Characteristics and Nursing Home Placement in Patients With Dementia
Yaffe, K. (2002) · JAMA · doi:10.1001/jama.287.16.2090 · Cited by 903
Self-citationSchneider, L. S., Dagerman, K., & Insel, P. S. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000200589.01396.6d · Cited by 903
Self-citationSynopsis of Psychiatry: 5th edn. Behavioral Sciences Clinical Psychiatry
Kaplan, H. I., & Sadock, B. J. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198907000-00008 · Cited by 852
Callahan, C. M., Boustani, M. A., Unverzagt, F. W., Austrom, M. G., Damush, T. M., Perkins, A. J., Fultz, B. A., Hui, S. L., Counsell, S. R., & Hendrie, H. C. (2006) · JAMA · doi:10.1001/jama.295.18.2148 · Cited by 798
Katz, I. R., Jeste, D. V., Mintzer, J. E., Clyde, C., Napolitano, J., Brecher, M., & The Risperidone Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0207 · Cited by 741
Self-citationA Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia
Schneider, L. S., Pollock, V. E., & Lyness, S. A. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb02407.x · Cited by 650 · cited 1×
“The overall average treatment effect was about 18%, a figure remarkably similar to that found in a meta-analysis of studies of conventional antipsychotics in this population (Schneider et al, 1990).”
ResultSelf-citationA randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia
De Deyn, P. P., Rabheru, K., Rasmussen, A., Bocksberger, J. P., Dautzenberg, P. L. J., Eriksson, S., & Lawlor, B. A. (1999) · Neurology · doi:10.1212/wnl.53.5.946 · Cited by 615
Kaufer, D. I., Cummings, J. L., Christine, D., Bray, T., Castellon, S., Masterman, D., MacMillan, A., Ketchel, P., & DeKosky, S. T. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb02542.x · Cited by 606
Evans, D. A., Funkenstein, H. H., Albert, M., Scherr, P. A., Cook, N. R., Chown, M. J., Hebert, L. E., Hennekens, C. H., & Taylor, J. O. (1989) · PubMed · Cited by 599
Cohen-Mansfield, J. (2001) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200111000-00005 · Cited by 593
Livingston, G., Johnston, K., Katona, C., Paton, J., Lyketsos, C. G., & Old Age Task Force of the World Federation of Biological Psychiatry (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.1996 · Cited by 591 · cited 2×
“Unfortunately, the evidence base for the efficacy of most psychosocial interventions in dementia patients is limited (Cohen-Mansfield, 2001; Livingston et al, 2005).”
BackgroundStreet, J. S. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.968 · Cited by 590
Atypical antipsychotics for aggression and psychosis in Alzheimer's disease
Ballard, C. G., Waite, J., & Birks, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003476.pub2 · Cited by 525
Aarsland, D., Bronnick, K., Ehrt, U., De Deyn, P. P., Tekin, S., Emre, M., & Cummings, J. L. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083113 · Cited by 521
Fossey, J., Ballard, C., Juszczak, E., James, I., Alder, N., Jacoby, R., & Howard, R. (2006) · BMJ · doi:10.1136/bmj.38782.575868.7c · Cited by 512
Brodaty, H., Ames, D., Snowdon, J., Woodward, M., Kirwan, J., Clarnette, R., Lee, E., Lyons, B., & Grossman, F. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0205 · Cited by 464
Ropacki, S. A., & Jeste, D. V. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2022 · Cited by 431
Self-citationEfficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia
Tariot, P. N., Erb, R., Podgorski, C. A., Cox, C., Patel, S., Jakimovich, L., & Irvine, C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.54 · Cited by 422
Self-citationGill, S. S., Rochon, P. A., Herrmann, N., Lee, P. E., Sykora, K., Gunraj, N., Normand, S.-L. T., Gurwitz, J. H., Marras, C., Wodchis, W. P., et al. (2005) · BMJ · doi:10.1136/bmj.38330.470486.8f · Cited by 402
Determinants of carer stress in Alzheimer's disease
Donaldson, C., Tarrier, N., & Burns, A. (1998) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199804)13:4<248::aid-gps770>3.0.co;2-0 · Cited by 400
Psychosis of Alzheimer's Disease and Related Dementias: Diagnostic Criteria for a Distinct Syndrome
Jeste, D. V., & Finkel, S. I. (2000) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200002000-00004 · Cited by 394
Self-citationSchneeweiss, S., Setoguchi, S., Brookhart, A., Dormuth, C., & Wang, P. S. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061250 · Cited by 366
Banerjee, S. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.072983 · Cited by 351
The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease
Holmes, C., Wilkinson, D., Dean, C., Vethanayagam, S., Olivieri, S., Langley, A., Pandita-Gunawardena, N. D., Hogg, F., Clare, C., & Damms, J. (2004) · Neurology · doi:10.1212/01.wnl.0000129990.32253.7b · Cited by 339
Treatment of agitation in AD: A randomized, placebo-controlled clinical trial
Teri, L., Logsdon, R. G., Peskind, E., Raskind, M., Weiner, M. F., Tractenberg, R. E., Foster, N. L., Schneider, L. S., Sano, M., Whitehouse, P., et al. (2000) · Neurology · doi:10.1212/wnl.55.9.1271 · Cited by 330
Self-citationPollock, B. G., Mulsant, B. H., Rosen, J., Sweet, R. A., Mazumdar, S., Bharucha, A., Marin, R., Jacob, N. J., Huber, K. A., Kastango, K. B., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.460 · Cited by 327
Ballard, C., Margallo-Lana, M., Juszczak, E., Douglas, S., Swann, A., Thomas, A., O'Brien, J., Everratt, A., Sadler, S., Maddison, C., et al. (2005) · BMJ · doi:10.1136/bmj.38369.459988.8f · Cited by 315
Tolerability of Atypical Antipsychotics
Stanniland, C., & Taylor, D. (2000) · Drug Safety · doi:10.2165/00002018-200022030-00004 · Cited by 303
Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type
Drevets, W. C., & Rubin, E. H. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90145-5 · Cited by 295
Zuidema, S. U., Derksen, E., Verhey, F. R. J., & Koopmans, R. T. C. M. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1722 · Cited by 274
Atypical Antipsychotics and Risk of Cerebrovascular Accidents
Herrmann, N., Mamdani, M., & Lanctôt, K. L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1113 · Cited by 273
Survival of Outpatients with Alzheimer-type Dementia
Walsh, J. S., Welch, H. G., & Larson, E. B. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-6-429 · Cited by 264
Buhr, G. T., Kuchibhatla, M., & Clipp, E. C. (2006) · The Gerontologist · doi:10.1093/geront/46.1.52 · Cited by 259
Racial Variation in Antidepressant Treatment in a Medicaid Population
Melfi, C. A., Croghan, T. W., Hanna, M. P., & Robinson, R. L. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0105 · Cited by 228
Lower Incidence of Tardive Dyskinesia with Risperidone Compared with Haloperidol in Older Patients
Jeste, D. V., Lacro, J. P., Bailey, A., Rockwell, E., Harris, M. J., & Caligiuri, M. P. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb01595.x · Cited by 226
Self-citationBehavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment
Cummings, J. L., Schneider, E., Tariot, P. N., & Graham, S. M. (2006) · Neurology · doi:10.1212/01.wnl.0000223333.42368.f1 · Cited by 223
Self-citationHaloperidol for agitation in dementia
Lonergan, E., Luxenberg, J., Colford, J. M., & Birks, J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002852 · Cited by 212
Ayalon, L. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.20.2182 · Cited by 212
Behavioral Pathology in Alzheimer’s Disease (BEHAVE-AD) Rating Scale
Reisberg, B., Auer, S. R., & Monteiro, I. M. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297003529 · Cited by 209
Placebo-Controlled Study of Divalproex Sodium for Agitation in Dementia
Porsteinsson, A. P., Tariot, P. N., Erb, R., Cox, C., Smith, E., Jakimovich, L., Noviasky, J., Kowalski, N., Holt, C. J., & Irvine, C. (2001) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200102000-00009 · Cited by 206
Self-citationQuality of Life measures for dementia.
Ready, R. E., & Ott, B. R. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-11 · Cited by 204
A FREQUENCY ADDENDUM TO THE BEHAVIORAL PATHOLOGY IN ALZHEIMER's DISEASE RATING SCALE (BEHAVE-AD)
Monteiro, I., Boksay, I., Auer, S. R., Torossian, C., Sinaiko, E., & Reisberg, B. (1999) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199911001-00147 · Cited by 201
Atypical antipsychotics and glucose dysregulation: a systematic review
Jin, H., Meyer, J. M., & Jeste, D. V. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.03.024 · Cited by 195
Self-citationConventional vs. Newer Antipsychotics in Elderly Patients
Jeste, D. V., Rockwell, E., Harris, M. J., Lohr, J. B., & Lacro, J. (1999) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199902000-00010 · Cited by 182
Self-citationEmergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease
Rosen, J., & Zubenko, G. S. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)91284-x · Cited by 179
Sultzer, D. L., Gray, K. F., Gunay, I., Berisford, M. A., & Mahler, M. E. (1997) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700510-00008 · Cited by 170
Do Atypical Antipsychotics Cause Stroke?
Herrmann, N., & Lanct??t, K. L. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00001 · Cited by 170
Olin, J. T., Fox, L. S., Pawluczyk, S., Taggart, N. A., & Schneider, L. S. (2001) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200111000-00008 · Cited by 163
Self-citationFinkel, S. I., Mintzer, J. E., Dysken, M. W., Krishnan, K., Burt, T., & McRae, T. D. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.998 · Cited by 163
Reducing Antipsychotic Drug Use in Nursing Homes: A Controlled Trial of Provider Education
Ray, W. A. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410060023005 · Cited by 159
Cummings, J. L., McRae, T., & Zhang, R. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000221293.91312.d3 · Cited by 159
Aripiprazole for the Treatment of Psychosis in Patients With Alzheimer's Disease
Deyn, P. P. D., Jeste, D. V., Swanink, R., Kostic, D., Breder, C. D., Carson, W. H., & Iwamoto, T. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000178415.22309.8f · Cited by 150
Self-citationQuetiapine to Treat Agitation in Dementia: A Randomized, Double-Blind,Placebo-Controlled Study
Zhong, K., Tariot, P. N., Mintzer, J., Minkwitz, M. C., & Devine, N. A. (2007) · Current Alzheimer Research · doi:10.2174/156720507779939805 · Cited by 145
Self-citationTariot, P. N., Schneider, L. S. S., Katz, I. R., Mintzer, J. E., Street, J. S., Copenhaver, M. D., & Williams-Hughes, C. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000196628.12010.35 · Cited by 145
Self-citationFrontotemporal Dementia: Behavioral Symptoms and Caregiver Distress
Mourik, J. C., Rosso, S. M., Niermeijer, M. F., Duivenvoorden, H. J., Swieten, J. C. V., & Tibben, A. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000080123 · Cited by 143
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
Glazer, W. M. (2000) · PubMed · Cited by 143
Peskind, E. R., Tsuang, D. W., Bonner, L. T., Pascualy, M., Riekse, R. G., Snowden, M. B., Thomas, R. G., & Raskind, M. A. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000155067.16313.5e · Cited by 134
Behavioral Disorders and Caregivers' Reaction in Taiwanese Patients With Alzheimer's Disease
Fuh, J., Liu, C.-K., Mega, M. S., Wang, S., & Cummings, J. L. (2001) · International Psychogeriatrics · doi:10.1017/s1041610201007517 · Cited by 131
Tariot, P. N., Raman, R., Jakimovich, L., Schneider, L., Porsteinsson, A., Thomas, R., Mintzer, J., Brenner, R., Schafer, K., & Thal, L. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.942 · Cited by 122
Self-citationChan, W. C., Lam, L. C. W., Choy, C. N. P., Leung, V., Li, S.-W., & Chiu, H. F. K. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.504 · Cited by 119
Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients
Coccaro, E. F., Kramer, E., Zemishlany, Z., Thorne, A., Rice, C. M., Giordani, B., Duvvi, K., Patel, B. M., Torres, J., & Nora, R. M. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.12.1640 · Cited by 115
Predictors of mortality in patients diagnosed with probable Alzheimer's disease
Bowen, J. D., Malter, A. D., Sheppard, L. A., Kukull, W. A., McCormick, W. C., Teri, L. L., & Larson, E. B. (1996) · Neurology · doi:10.1212/wnl.47.2.433 · Cited by 115
Sival, R. C., Haffmans, P. M. J., Jansen, P. A. F., Duursma, S. A., & Eikelenboom, P. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.653 · Cited by 114
Ballard, C. G., & Waite, J. (2006) · Research Portal (King's College London) · Cited by 112
Dolder, C. R., & Jeste, D. V. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00170-7 · Cited by 102
Self-citationMatsui, T., Nakaaki, S., Murata, Y., Sato, J., Shinagawa, Y., Tatsumi, H., & Furukawa, T. A. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000090744 · Cited by 100
Raivio, M. M., Laurila, J. V., Strandberg, T. E., Tilvis, R. S., & Pitkälä, K. H. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31802d0b00 · Cited by 99
Keene, J., Hope, T., Fairburn, C. G., & Jacoby, R. J. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.474 · Cited by 97
Herrmann, N., Rabheru, K., Wang, J., & Binder, C. E. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.6.527 · Cited by 96
Gabapentin in the Treatment of Cocaine Dependence
Myrick, H., Henderson, S., Brady, K. T., & Malcolm, R. J. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0105 · Cited by 95
Tardive dyskinesia in older patients.
Jeste, D. V. (2000) · PubMed · Cited by 94
Self-citationNeuroleptics and Alternative Treatments
Wragg, R. E., & Jeste, D. V. (1988) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30524-0 · Cited by 93
Self-citationKindermann, S. S., Dolder, C. R., Bailey, A. L., Katz, I. R., & Jeste, D. V. (2002) · Drugs & Aging · doi:10.2165/00002512-200219040-00002 · Cited by 86
Self-citationImmediate causes of death of demented and non-demented elderly
Kammoun, S., Gold, G., Bouras, C., Giannakopoulos, P., McGee, W., Herrmann, F. R., & Michel, J.-P. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00314.x · Cited by 83
Wragg, R. E., & Jeste, D. V. (1988) · PubMed · Cited by 82
Self-citationPrevalence and correlates of disruptive behavior in patients in Norwegian nursing homes
Testad, I., Aasland, A. M., & Aarsland, D. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1766 · Cited by 77
Brodaty, H., & Low, L. (2003) · PubMed · Cited by 76
Late-Life Depression: A Model for Medical Classification
Alexopoulos, G. S., Schultz, S. K., & Lebowitz, B. D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.055 · Cited by 75
Hallucinations, Cognitive Decline, and Death in Alzheimer’s Disease
Wilson, R. S., Tang, Y., Aggarwal, N. T., Gilley, D. W., McCann, J. J., Bienias, J. L., & Evans, D. A. (2006) · Neuroepidemiology · doi:10.1159/000090251 · Cited by 73
Suh, G., Son, H.-G., Ju, Y., Jcho, K. H., Yeon, B. K., Shin, Y. M., Kee, B. S., & Choi, S. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200409000-00009 · Cited by 71
Lanctôt, K. L., Herrmann, N., van Reekum, R., Eryavec, G. M., & Naranjo, C. A. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.636 · Cited by 70
Murman, D. L., & Colenda, C. C. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523030-00004 · Cited by 65
Hall, K. A., Keks, N. A., & O’Connor, D. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205001535 · Cited by 65
Ritsner, M. S., Gibel, A., Perelroyzen, G., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000144895.75728.2b · Cited by 64
Nasrallah, H. A., White, T., & Nasrallah, A. T. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200407000-00012 · Cited by 63
Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's Disease Trial
Schneider, L. S. S., Ismail, M. S., Dagerman, K., Davis, S. M., Olin, J. T., McManus, D., Pfeiffer, E., Ryan, J. M., Sultzer, D. L., & Tariot, P. N. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006991 · Cited by 59
Self-citationJeste, D. V., Meeks, T. W., Kim, D. S., & Zubenko, G. S. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706291087 · Cited by 59
Self-citationClinical Features and Mortality in Patients with Early-Onset Alzheimer’s Disease
Samson, W. N., van Duijn, C. M., Hop, W. C. J., & Albert Hofman, D. (2008) · European Neurology · doi:10.1159/000117218 · Cited by 58
Off-Label Use of Antipsychotic Drugs
Weiss, E. M., Hummer, M., Koller, D., Ulmer, H., & Fleischhacker, W. W. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00018 · Cited by 53
Cantillon, M., Brunswick, R., Molina, D. H., & Bahro, M. (1996) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199622430-00011 · Cited by 51
Christensen, D. B., & Benfield, W. R. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb01081.x · Cited by 51
The BPRS: psychometric developments.
Bech, P., Larsen, J. K., & Andersen, J. (1988) · PubMed · Cited by 43
The measuring, meaning and importance of activities of daily living (ADLs) as an outcome
Rockwood, K. J. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207004966 · Cited by 39
Comorbidity of Psychopathological Domains in Community-Dwelling Persons with Alzheimer's Disease
Tractenberg, R. E., Weiner, M., Patterson, M. B., Teri, L. L., & Thal, L. J. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988703016002006 · Cited by 38
Trinh, N.-H., Hoblyn, J., Mohanty, S., & Yaffe, K. (2003) · JAMA · doi:10.1001/jama.289.2.210 · Cited by 37
Self-citationDeyn, P. P. D., & Wirshing, W. C. (2001) · PubMed · Cited by 36
Behavioral Characteristics of Agitated Nursing Home Residents With Dementia at the End of Life
Allen, R. S., Burgio, L. D., Fisher, S. E., et al. (2005) · The Gerontologist · doi:10.1093/geront/45.5.661 · Cited by 32
Persistence of and Changes in Neuropsychiatric Symptoms in Alzheimer Disease Over 6 Months
Ryu, S.-H., Katona, C., Rive, B., & Livingston, G. (2005) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200511000-00008 · Cited by 22
Clinical Trials in Late-Life Depression: Revisited
Roose, S. P., & Sackeïm, H. A. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200209000-00002 · Cited by 18
Fluvoxamine for Psychosis in Alzheimer's Disease
Levkovitz, Y., Bloch, Y., Kaplan, D., Diskin, A., & Abramovitchi, I. (2001) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200102000-00011 · Cited by 16
Prevalence and correlates of dementia: survey of the last days of life.
Losonczy, K. G., White, L. R., & Db, B. (1998) · PubMed · Cited by 16
Clinical trials in geriatric disorders
Ownby, R. L. (2001) · Current Psychiatry Reports · doi:10.1007/s11920-001-0065-3 · Cited by 2
Cited by
Management of agitation and aggression associated with Alzheimer disease
Ballard, C. G., Gauthier, S., Cummings, J. L., Brodaty, H., Grossberg, G. T., Robert, P., & Lyketsos, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.39 · Cited by 404
Management of behavioral problems in Alzheimer's disease
Gauthier, S., Cummings, J., Ballard, C., Brodaty, H., Grossberg, G., Robert, P., & Lyketsos, C. (2010) · International Psychogeriatrics · doi:10.1017/s1041610209991505 · Cited by 361
Antidepressants for agitation and psychosis in dementia
Seitz, D. P., Adunuri, N., Gill, S. S., Gruneir, A., Herrmann, N., & Rochon, P. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008191.pub2 · Cited by 304
Freudenmann, R. W., & Lepping, P. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00018-09 · Cited by 282
Crystal, S., Olfson, M., Huang, C., Pincus, H., & Gerhard, T. (2009) · Health Affairs · doi:10.1377/hlthaff.28.5.w770 · Cited by 268
Metadata
- Authors
- Jeste, D. V., Blazer, D., Casey, D., Meeks, T., Salzman, C., Schneider, L., Tariot, P., & Yaffe, K.
- Venue
- Neuropsychopharmacology
- Published
- 2007-07-18
- Volume
- 33
- Issue
- 5
- Pages
- 957-970
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2058762304
- Cited by
- 365
- References
- 116
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.